Combined antibiotic and NSAID offers new BRD treatment

Ceva Animal Health has launched a new treatment option for bovine respiratory disease (BRD). Zeleris contains a combination of active ingredients – florfenicol and meloxicam. Ceva says the product has been developed in response to demand from farm animal vets and says the treatment offers: A specific combination of florfenicol and meloxicam for the treatment of BRD; Easy-to-remember 1 ml/10 kg dose rate; Single shot; Hi-tech, shock-resistant vial is ideal for farm conditions; Excellent syringeability, even at low temperatures; Available in 100 ml and 250 ml sizes at launch and 50 ml in early 2018. Ceva says the syringeabilty of Zeleris is proven to be four times faster than similar treatments, ‘even on cold days’, adding that it ‘could soon become the product of choice’. Ruth Vernon, consultant veterinary surgeon, says: ‘BRD remains the most significant cause of death in youngstock...
Source: Veterinary Record - Category: Veterinary Research Tags: Products and Services Source Type: research